Danaher Gross Profit 2010-2024 | DHR
Danaher annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Danaher gross profit for the quarter ending December 31, 2024 was $3.890B, a 2.94% increase year-over-year.
- Danaher gross profit for the twelve months ending December 31, 2024 was $14.206B, a 1.23% increase year-over-year.
- Danaher annual gross profit for 2024 was $14.206B, a 1.23% increase from 2023.
- Danaher annual gross profit for 2023 was $14.034B, a 13.31% decline from 2022.
- Danaher annual gross profit for 2022 was $16.188B, a 6.23% increase from 2021.
| Danaher Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $14,206 |
| 2023 | $14,034 |
| 2022 | $16,188 |
| 2021 | $15,239 |
| 2020 | $12,475 |
| 2019 | $9,984 |
| 2018 | $9,505 |
| 2017 | $8,571 |
| 2016 | $9,335 |
| 2015 | $7,771 |
| 2014 | $6,850 |
| 2013 | $9,342 |
| 2012 | $9,414 |
| 2011 | $8,177 |
| 2010 | $6,405 |
| 2009 | $5,070 |
| Danaher Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-12-31 | $3,890 |
| 2024-09-30 | $3,401 |
| 2024-06-30 | $3,428 |
| 2024-03-31 | $3,487 |
| 2023-12-31 | $3,779 |
| 2023-09-30 | $3,275 |
| 2023-06-30 | $3,318 |
| 2023-03-31 | $3,662 |
| 2022-12-31 | $2,178 |
| 2022-09-30 | $4,584 |
| 2022-06-30 | $4,721 |
| 2022-03-31 | $4,705 |
| 2021-12-31 | $2,230 |
| 2021-09-30 | $4,359 |
| 2021-06-30 | $4,397 |
| 2021-03-31 | $4,253 |
| 2020-12-31 | $3,954 |
| 2020-09-30 | $3,226 |
| 2020-06-30 | $2,852 |
| 2020-03-31 | $2,443 |
| 2019-12-31 | $2,704 |
| 2019-09-30 | $2,441 |
| 2019-06-30 | $2,484 |
| 2019-03-31 | $2,355 |
| 2018-12-31 | $1,354 |
| 2018-09-30 | $2,691 |
| 2018-06-30 | $2,817 |
| 2018-03-31 | $2,644 |
| 2017-12-31 | $1,218 |
| 2017-09-30 | $2,537 |
| 2017-06-30 | $2,482 |
| 2017-03-31 | $2,334 |
| 2016-12-31 | $2,500 |
| 2016-09-30 | $2,286 |
| 2016-06-30 | $2,381 |
| 2016-03-31 | $2,167 |
| 2015-12-31 | $766 |
| 2015-09-30 | $1,893 |
| 2015-06-30 | $2,644 |
| 2015-03-31 | $2,468 |
| 2014-12-31 | $2,804 |
| 2014-09-30 | $2,452 |
| 2014-06-30 | $2,620 |
| 2014-03-31 | $2,453 |
| 2013-12-31 | $2,712 |
| 2013-09-30 | $2,425 |
| 2013-06-30 | $2,496 |
| 2013-03-31 | $2,326 |
| 2012-12-31 | $2,545 |
| 2012-09-30 | $2,278 |
| 2012-06-30 | $2,356 |
| 2012-03-31 | $2,236 |
| 2011-12-31 | $2,327 |
| 2011-09-30 | $2,183 |
| 2011-06-30 | $1,918 |
| 2011-03-31 | $1,749 |
| 2010-12-31 | $1,718 |
| 2010-09-30 | $1,612 |
| 2010-06-30 | $1,606 |
| 2010-03-31 | $1,469 |
| 2009-12-31 | $1,228 |
| 2009-09-30 | $1,321 |
| 2009-06-30 | $1,262 |
| 2009-03-31 | $1,259 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $146.516B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.469B | 13.19 |
| CVS Health (CVS) | United States | $85.419B | 12.50 |
| Cencora (COR) | United States | $53.926B | 19.57 |
| DiDi Global (DIDIY) | China | $23.525B | 0.00 |
| Natera (NTRA) | United States | $19.117B | 0.00 |
| BioMerieux (BMXMF) | France | $14.914B | 0.00 |
| ICON (ICLR) | Ireland | $14.132B | 12.84 |
| Solventum (SOLV) | United States | $13.154B | 12.27 |
| Revvity (RVTY) | United States | $12.712B | 21.59 |
| Avantor (AVTR) | United States | $11.045B | 16.21 |
| CochLear (CHEOY) | Australia | $10.877B | 0.00 |
| Doximity (DOCS) | United States | $10.834B | 56.34 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
| Viatris (VTRS) | United States | $10.397B | 3.29 |
| Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
| HealthEquity (HQY) | United States | $7.644B | 37.60 |
| Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
| Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
| Organon (OGN) | United States | $3.841B | 3.91 |
| Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
| Sotera Health (SHC) | United States | $3.305B | 19.11 |
| BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
| Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
| Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
| Progyny (PGNY) | United States | $1.908B | 42.15 |
| Agilon Health (AGL) | United States | $1.785B | 0.00 |
| Premier (PINC) | United States | $1.760B | 11.27 |
| PACS (PACS) | United States | $1.713B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
| Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
| CareDx (CDNA) | United States | $0.984B | 16.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
| Embecta (EMBC) | United States | $0.741B | 5.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
| Enhabit (EHAB) | United States | $0.444B | 41.86 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.269B | 11.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
| Nutex Health (NUTX) | United States | $0.256B | 5.10 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.168B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| So-Young (SY) | China | $0.098B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.056B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.57 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |